CMS rulemaking or Congress should remove the outdated coverage exclusion on obesity treatment for Medicare beneficiaries.

Medicare will expand coverage for GLP-1 drugs. Here's how this new development will affect you if you are on Medicare ...

Cigna (CI) is ending coverage for GLP-1 weight-loss drugs such as Eli Lilly's (LLY) Zepbound and Novo Nordisk’s (NVO) Wegovy ...

WASHINGTON, DC - OCTOBER 06: Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS) building Your father’s rheumatoid arthritis ...

May 28 (Reuters) - CVS Health will add Eli Lilly's weight-loss drug Zepbound back to some of its drug lists as an additional ...

Medicare Part D prescription drug plans are administered by private insurers. Most Medicare Advantage (Part C) plans also provide medication coverage. The covered medications and costs can vary. Part ...

Medicare open enrollment, which lasts until Dec. 7, provides beneficiaries the opportunity to evaluate their health care spending, including prescription costs, for 2026. Certain changes, including a ...

CVS Health will restore Eli Lilly’s weight-loss injection Zepbound to its list of covered drugs and also add the drugmaker’s ...

By Amina Niasse NEW YORK, June 2 (Reuters) - Health insurer Cigna will stop covering GLP-1 weight-loss drugs including Novo ...

Coverage ends July 1: Cigna will halt coverage of GLP-1 weight-loss drugs for its employees, though diabetes prescriptions remain unaffected. Cash-pay alternative: Employees may buy drugs directly ...